Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...

替尔泊肽的国际化上市进程稳步推进。2022年5月，它率先在美国获得FDA批准，用于改善成人2型糖尿病患者的血糖控制。2023年11月，FDA再次批准其用于慢性体重管理，这让替尔泊肽成功进军减重市场。

为探究可卡因成瘾神经机制及治疗新策略，美国宾夕法尼亚大学研究人员开展关于中枢 GLP-1 信号在可卡因觅药行为中作用的研究，发现激活相关神经回路可减少可卡因觅药行为，为治疗可卡因使用障碍（CUD）提供新思路。

A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

Insulin resistance in T1D is more common than you think, and without early intervention, these patients face increased risks ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Taiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists ...